Intended for healthcare professionals


National Institutes of Health criticised for not preventing conflicts of interest

BMJ 2004; 329 doi: (Published 01 July 2004) Cite this as: BMJ 2004;329:10
  1. Janice Hopkins Tanne
  1. New York

    The US National Institutes of Health (NIH) has been criticised by members of Congress for letting employees accept lucrative consultancy assignments from drug and biotechnology companies.

    On 22 June the director of the NIH, Dr Elias Zerhouni, told the House Energy and Commerce Oversight and Investigations Subcommittee, “In retrospect, there was not a sufficient safeguard against the perception of conflict of interest.” He said the NIH would tighten rules about employees' consultancy work.

    The NIH's troubles began on 7 December 2003. …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription